facebook-page-view
Advertisement

A Velumani

Premium
Sector watch: Will COVID-19 strengthen big diagnostics firms, spur consolidation?

Healthcare

30 October, 2020

Sector watch: Will COVID-19 strengthen big diagnostics firms, spur consolidation?

When Nalanda Capital bet on Thyrocare Technologies Ltd in March, the private equity-style investor in public equities was likely enticed ......

Premium
Nalanda Capital-backed Thyrocare to appoint first new CEO in 25 years

Healthcare

11 September, 2020

Nalanda Capital-backed Thyrocare to appoint first new CEO in 25 years

Thyrocare Technologies Ltd, which has been led since 1995 by founder Arokiaswamy Velumani, is set to get a new chief ......

PE-backed pathology chains get a shot in the arm as SC tweaks virus testing order

Healthcare

13 April, 2020

PE-backed pathology chains get a shot in the arm as SC tweaks virus testing order

The Supreme Court on Monday modified its recent order that had made it mandatory for private-sector pathology chains like Dr ......

Premium
COVID-19 tests to be small part of biz, won't delight investors: Thyrocare founder

Healthcare

06 April, 2020

COVID-19 tests to be small part of biz, won't delight investors: Thyrocare founder

Last month, the Indian government allowed some accredited private labs to test coronavirus samples. The move was seen as a ......

Premium
Nalanda sniffs opportunity in coronavirus outbreak, makes first-ever healthcare bet

Healthcare

26 March, 2020

Nalanda sniffs opportunity in coronavirus outbreak, makes first-ever healthcare bet

Nalanda Capital, an India-focused private equity-style investor in public equities, has bought a minority stake in a diagnostics services provider ......

Premium
Coronavirus: Pathology chains wait on the sidelines, device makers gear up

Healthcare

16 March, 2020

Coronavirus: Pathology chains wait on the sidelines, device makers gear up

The number of confirmed coronavirus cases (COVID-19), which was declared a pandemic by the World Health Organization (WHO) last week, ......

Premium
Diagnostics firms shouldn't fear price controls: Panellists at VCCircle summit

Healthcare

11 October, 2019

Diagnostics firms shouldn't fear price controls: Panellists at VCCircle summit

Diagnostics companies must focus on providing good-quality services and building sustainable business models instead of worrying about government moves to ......

Premium
Diagnostics firms should still get fair valuation in IPOs: Thyrocare's Velumani

Healthcare

16 November, 2018

Diagnostics firms should still get fair valuation in IPOs: Thyrocare's Velumani

Thyrocare Technologies Ltd had made a spectacular debut on the stock exchanges two years ago. But its share prices have ......

Thyrocare founder A Velumani on why diagnostics sector draws PE interest and more

Healthcare

13 November, 2018

Thyrocare founder A Velumani on why diagnostics sector draws PE interest and more

The diagnostics sector in India has seen plenty of action in recent years, with some companies going public and some ......

Diagnostics sector still attractive to PEs: Thyrocare's Velumani at VCCircle event

Healthcare

09 October, 2018

Diagnostics sector still attractive to PEs: Thyrocare's Velumani at VCCircle event

The diagnostics sector continues to attract investor interest even as valuations have tempered over the past two years, a top ......